Life Sciences Law360 provides breaking legal news and analysis on the
pharmaceutical and medical device industry. Coverage includes high-stakes
litigation and policy developments that affect life sciences companies, as well
as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
November 03, 2026
A Georgia federal court's recent decision in MiMedx v. U.S. Food and Drug Administration constrains the FDA's analytical framework for classifying certain wound care products as biological products, carrying important ramifications for manufacturers seeking to avoid heightened regulatory requirements, say attorneys at Hyman Phelps.
-
November 02, 2026
Investors of now-bankrupt vaccine company Gritstone Bio Inc. have asked a California federal court to grant final approval to a $6 million settlement resolving claims that its former CEO failed to disclose the company's inability to carry out a $423 million government contract for COVID-19 vaccine research it was granted in 2023.
-
November 02, 2026
A New Jersey federal judge tossed a proposed class action Friday challenging the Garden State's practice of keeping newborn babies' residual blood spots without parental consent, finding the parents haven't alleged viable Fourth or Fourteenth Amendment claims, in part because the state agreed to destroy the blood spots at issue.
-
November 02, 2026
A Maryland federal judge has refused to let a British healthcare company dodge a lawsuit alleging it stole trade secrets relating to a novel method of treating depression with psilocybin, the active ingredient in psychoactive mushrooms.
-
November 02, 2026
Splenda maker TC Heartland LLC urged the Fourth Circuit to revive its defamation suit against a scientist over her public warnings about the sweetener, arguing that the First Amendment does not shield statements that misrepresent research or rely on concealed test results.
See more Life Sciences news